全文获取类型
收费全文 | 667篇 |
免费 | 42篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 27篇 |
妇产科学 | 17篇 |
基础医学 | 108篇 |
口腔科学 | 38篇 |
临床医学 | 87篇 |
内科学 | 125篇 |
皮肤病学 | 4篇 |
神经病学 | 26篇 |
特种医学 | 65篇 |
外科学 | 102篇 |
综合类 | 12篇 |
一般理论 | 1篇 |
预防医学 | 36篇 |
眼科学 | 4篇 |
药学 | 41篇 |
中国医学 | 2篇 |
肿瘤学 | 14篇 |
出版年
2019年 | 3篇 |
2018年 | 13篇 |
2017年 | 6篇 |
2016年 | 6篇 |
2015年 | 22篇 |
2014年 | 26篇 |
2013年 | 26篇 |
2012年 | 26篇 |
2011年 | 10篇 |
2010年 | 19篇 |
2009年 | 15篇 |
2008年 | 18篇 |
2007年 | 13篇 |
2006年 | 17篇 |
2005年 | 14篇 |
2004年 | 8篇 |
2003年 | 8篇 |
2002年 | 16篇 |
2001年 | 11篇 |
2000年 | 17篇 |
1999年 | 13篇 |
1998年 | 10篇 |
1997年 | 16篇 |
1996年 | 17篇 |
1995年 | 16篇 |
1994年 | 17篇 |
1993年 | 16篇 |
1992年 | 15篇 |
1991年 | 17篇 |
1990年 | 19篇 |
1989年 | 26篇 |
1988年 | 17篇 |
1987年 | 19篇 |
1986年 | 20篇 |
1985年 | 15篇 |
1984年 | 19篇 |
1983年 | 14篇 |
1982年 | 5篇 |
1981年 | 10篇 |
1980年 | 19篇 |
1979年 | 9篇 |
1978年 | 10篇 |
1977年 | 11篇 |
1976年 | 14篇 |
1975年 | 10篇 |
1974年 | 9篇 |
1973年 | 5篇 |
1972年 | 4篇 |
1971年 | 8篇 |
1904年 | 2篇 |
排序方式: 共有712条查询结果,搜索用时 31 毫秒
21.
Posttraumatic or acute instability of the elbow can develop after complete or incomplete dislocation of the elbow. Isolated medial collateral ligament ruptures can be a result of valgus trauma and lateral collateral ligament ruptures of pivot shift or varus trauma. Chronic instability of the elbow may occur after conservative or operative treatment of a traumatic ligament rupture without stable healing. Repetitive overuse in sports or professions may also cause chronic instability. This article provides the reader an overview about current concepts in elbow instability. 相似文献
22.
Etienne Gayat Alexa Hollinger Alain Cariou Nicolas Deye Antoine Vieillard-Baron Samir Jaber Benjamin G. Chousterman Qin Lu Pierre François Laterre Xavier Monnet Michael Darmon Marc Leone Bertrand Guidet Romain Sonneville Jean-Yves Lefrant Marie-Céline Fournier Matthieu Resche-Rigon Alexandre Mebazaa Matthieu Legrand On behalf of FROG-ICU investigators 《Intensive care medicine》2018,44(5):598-605
23.
Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study 总被引:10,自引:0,他引:10
Seeff LB Hollinger FB Alter HJ Wright EC Cain CM Buskell ZJ Ishak KG Iber FL Toro D Samanta A Koretz RL Perrillo RP Goodman ZD Knodell RG Gitnick G Morgan TR Schiff ER Lasky S Stevens C Vlahcevic RZ Weinshel E Tanwandee T Lin HJ Barbosa L 《Hepatology (Baltimore, Md.)》2001,33(2):455-463
Persons with non-A, non-B hepatitis (cases) identified in 5 transfusion studies in the early 1970s have been followed ever since and compared for outcome with matched, transfused, non-hepatitis controls from the same studies. Previously, we reported no difference in all-cause mortality but slightly increased liver-related mortality between these cohorts after 18 years follow-up. We now present mortality and morbidity data after approximately 25 years of follow-up, restricted to the 3 studies with archived original sera. All-cause mortality was 67% among 222 hepatitis C-related cases and 65% among 377 controls (P = NS). Liver-related mortality was 4.1% and 1.3%, respectively (P =.05). Of 129 living persons with previously diagnosed transfusion-associated hepatitis (TAH), 90 (70%) had proven TAH-C, and 39 (30%), non-A-G hepatitis. Follow-up of the 90 TAH-C cases revealed viremia with chronic hepatitis in 38%, viremia without chronic hepatitis in 39%, anti-HCV without viremia in 17%, and no residual HCV markers in 7%. Thirty-five percent of 20 TAH-C patients biopsied for biochemically defined chronic hepatitis displayed cirrhosis, representing 17% of all those originally HCV-infected. Clinically evident liver disease was observed in 86% with cirrhosis but in only 23% with chronic hepatitis alone. Thirty percent of non-A, non-B hepatitis cases were unrelated to hepatitis viruses A,B,C, and G, suggesting another unidentified agent. In conclusion, all-cause mortality approximately 25 years after acute TAH-C is high but is no different between cases and controls. Liver-related mortality attributable to chronic hepatitis C, though low (<3%), is significantly higher among the cases. Among living patients originally HCV-infected, 23% have spontaneously lost HCV RNA. 相似文献
24.
25.
Effect of acute lung injury on angiotensin converting enzyme in serum, lung lavage, and effusate 总被引:7,自引:0,他引:7
M A Hollinger S N Giri S Patwell J E Zuckerman A Gorin G Parsons 《The American review of respiratory disease》1980,121(2):373-376
The administration of an acute pulmonary edemagenic dose (ip) of thiourea to rats results in an elevation of angiotensin converting enzyme (ACE) in serum, lung lavage, and pleural effusion. The increased serum ACE corresponds to a reduction in lung ACE, but it is transient, lasting between 1 and 2 h. ACE remains elevated in lung lavage and pleural effusion for at least 4 h after the administration of thiourea. 相似文献
26.
27.
Occult hepatitis B (OHB) infection has been reported to play an important role in the development of hepatocellular carcinoma (HCC). In this systematic review, a significantly higher prevalence of OHB was observed in patients with HCC in the presence or absence of HCV infection when compared with control populations without HCC. Correspondingly, among adequately designed prospective studies, the cumulative probability of developing HCC was significantly greater among patients with OHB than among HBV DNA‐negative patients in the presence or absence of HCV infection. Study design, inclusion criteria, treatment options, methodology and potential confounding variables were evaluated, and immunopathogenic mechanisms that could be involved in OHB as a risk factor in HCC were reviewed. From this analysis, we conclude that although OHB is an independent risk factor in HCC development in anti‐HCV‐negative patients, a synergistic or additive role in the occurrence of HCC in HCV‐coinfected patients is more problematic due to the HCC risk attributable to HCV alone, especially in patients with advanced fibrosis and cirrhosis. 相似文献
28.
YENN‐JIANG LIN M.D. SHIH‐LIN CHANG M.D. LI‐WEI LO M.D. YU‐FENG HU M.D. KAZUYOSHI SUENARI M.D. CHENG‐HUNG LI M.D. TZE‐FAN CHAO M.D. FA‐PO CHUNG M.D. JO‐NAN LIAO M.D. BENY HARTONO M.D. HAN‐WEN TSO Ph.D. HSUAN‐MING TSAO M.D. JIN‐LONG HUANG M.D. TSAIR KAO Ph.D. SHIH‐ANN CHEN M.D. 《Journal of cardiovascular electrophysiology》2012,23(11):1155-1162
Modified Pulmonary Vein Isolation in AF Ablation. Introduction: Pulmonary vein isolation (PVI) is the primary ablation therapy in patients with atrial fibrillation (AF). We hypothesized that high dominant frequency (DF) sites (AF nests during sinus rhythm [SR]) adjacent to the PV ostia are associated with the atrial substrate that maintains AF, and PVI incorporating the high‐frequency AF nests may have a higher efficacy. Methods and Results: In a prospective and randomized comparison, 126 symptomatic paroxysmal AF patients that underwent PVI were enrolled. We compared the efficacy of a modified PVI (ablation line: 1.0–1.5 cm from the PV ostium with encircling the AF nests [spectral analysis with DF >70 Hz during SR, Group II]) versus the anatomy‐guided conventional PVI (Group I). In Group II, the DF value along the PV ostium was lower than 70 Hz after the PVI. The primary endpoint was the freedom from symptomatic atrial arrhythmias after a single procedure. We also followed the autonomic function by a time‐domain analysis of the heart rate variability. In both groups, AF nests were observed and electric isolation was successfully obtained in all patients. With a mean duration of 16 ± 6.1 months of follow‐up, Group II had a higher single procedure efficacy without drugs (78.7% vs 66.1%, log‐rank test: P = 0.02), and fewer repeat procedures (6.6% vs 23%; P = 0.04), as compared to Group I. Conclusion: PVI incorporating the high frequency AF nests adjacent to the PV ostia had a better single procedure efficacy. (J Cardiovasc Electrophysiol, Vol. 23, pp. 1155–1162, November 2012) 相似文献
29.
Flora Yan Erika Rauscher Amanda Hollinger Mary Ann Caputo John Ready Carole Fakhry Cherie‐Ann O. Nathan Chris Leonardis Danielle Yearout Terance T. Tsue Terry A. Day Michael G. Moore 《Head & neck》2020,42(7):1526-1532
The COVID‐19 pandemic has had a significant impact on many aspects of head and neck cancer (HNC) care. The uncertainty and stress resulting from these changes has led many patients and caregivers to turn to HNC advocacy groups for guidance and support. Here we outline some of the issues being faced by patients with HNC during the current crisis and provide examples of programs being developed by advocacy groups to address them. We also highlight the increased utilization of these organizations that has been observed as well as some of the challenges being faced by these not‐for‐profit groups as they work to serve the head and neck community. 相似文献
30.
Fabricio Ferreira COELHO Marcos Vinícius PERINI Jaime Arthur Pirola KRUGER Gilton Marques FONSECA Raphael Leonardo Cunha de ARAúJO Fábio Ferrari MAKDISSI Renato Micelli LUPINACCI Paulo HERMAN 《Brazilian archives of digestive surgery》2014,27(2):138-144